Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

154: AI in Pathology: Advances in Prostate, Bladder & Endocrine Cancer

20:43
 
Share
 

Manage episode 501189421 series 3404634
Content provided by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

If our visual scoring is still based on gut feeling, how do we scale precision?
In this week’s DigiPath Digest, I explored four new AI-focused papers that could reshape how we diagnose prostate, bladder, gastroesophageal, and endocrine cancers.

From automated IHC scoring to predicting urethral recurrence post-cystectomy, these studies highlight the growing value—and responsibility—of integrating AI into our pathology workflows.

And yes, I also reveal where to get my histology-inspired earrings 😉

Episode Highlights

[06:00] Muse Vet Platform launch + STP talk
[11:00] Tools I use: Perplexity, RAG, ChatGPT, and AI citation traps
[14:00] AI’s promise—and its pitfalls

Paper 1: IHC Scoring in GEC (Caputo et al.)

Manual PD-L1 and HER2 scoring is subjective. This study shows AI can standardize and improve accuracy using digital tools for GEC.

[20:00] AI reduces visual bias
[23:00] Potential to replace expensive assays

Paper 2: ASAP in Prostate Biopsies

Page Prostate AI matched final diagnoses 85% of the time—more than human reviewers.

[24:00] ASAP = gray zone diagnosis
[27:00] AI matched final calls more often than humans

Paper 3: Recurrence Prediction Post-Cystectomy

Chinese study developed a recurrence model using ML on clinical data. AUC: 0.86 (train), 0.77 (test).

[30:00] Risk factors: CIS, bladder neck involvement
[32:00] SHAP explained model insights

Paper 4: Reticulin Framework in Endocrine Pathology

Reticulin stains are cheap but powerful. This paper calls for AI to take notice.

[36:00] Reticulin separates benign from malignant
[40:00] Let’s train AI on these patterns

📚 Resource from this Episode

  • Caputo et al., Pathology Research & Practice
  • Page Prostate study on ASAP
  • ML model predicting urethral recurrence
  • Reticulin stains in endocrine tumor grading

AI is already enhancing diagnostic precision—we just need to guide its use responsibly. From special stains to advanced models, this episode covers where we're headed next.

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!

  continue reading

167 episodes

Artwork
iconShare
 
Manage episode 501189421 series 3404634
Content provided by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Aleksandra Zuraw, DVM, PhD, Aleksandra Zuraw, and DVM or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text

If our visual scoring is still based on gut feeling, how do we scale precision?
In this week’s DigiPath Digest, I explored four new AI-focused papers that could reshape how we diagnose prostate, bladder, gastroesophageal, and endocrine cancers.

From automated IHC scoring to predicting urethral recurrence post-cystectomy, these studies highlight the growing value—and responsibility—of integrating AI into our pathology workflows.

And yes, I also reveal where to get my histology-inspired earrings 😉

Episode Highlights

[06:00] Muse Vet Platform launch + STP talk
[11:00] Tools I use: Perplexity, RAG, ChatGPT, and AI citation traps
[14:00] AI’s promise—and its pitfalls

Paper 1: IHC Scoring in GEC (Caputo et al.)

Manual PD-L1 and HER2 scoring is subjective. This study shows AI can standardize and improve accuracy using digital tools for GEC.

[20:00] AI reduces visual bias
[23:00] Potential to replace expensive assays

Paper 2: ASAP in Prostate Biopsies

Page Prostate AI matched final diagnoses 85% of the time—more than human reviewers.

[24:00] ASAP = gray zone diagnosis
[27:00] AI matched final calls more often than humans

Paper 3: Recurrence Prediction Post-Cystectomy

Chinese study developed a recurrence model using ML on clinical data. AUC: 0.86 (train), 0.77 (test).

[30:00] Risk factors: CIS, bladder neck involvement
[32:00] SHAP explained model insights

Paper 4: Reticulin Framework in Endocrine Pathology

Reticulin stains are cheap but powerful. This paper calls for AI to take notice.

[36:00] Reticulin separates benign from malignant
[40:00] Let’s train AI on these patterns

📚 Resource from this Episode

  • Caputo et al., Pathology Research & Practice
  • Page Prostate study on ASAP
  • ML model predicting urethral recurrence
  • Reticulin stains in endocrine tumor grading

AI is already enhancing diagnostic precision—we just need to guide its use responsibly. From special stains to advanced models, this episode covers where we're headed next.

Support the show

Get the "Digital Pathology 101" FREE E-book and join us!

  continue reading

167 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play